Literature DB >> 20947041

Ex vivo evaluation of coronary atherosclerotic plaques: characterization with dual-source CT in comparison with histopathology.

Sebastian Leschka1, Sara Seitun, Matthias Dettmer, Stephan Baumüller, Paul Stolzmann, Robert Goetti, Hans Scheffel, Gudrun Feuchtner, Kathrin Wunnicke, Simon Wildermuth, Christian Oehlschlegel, Borut Marincek, Wolfram Jochum, Hatem Alkadhi.   

Abstract

BACKGROUND: Identification and differentiation of coronary atherosclerotic plaques may improve risk stratification for incident coronary events.
OBJECTIVE: We investigated the ability of dual-source computed tomography (CT) to depict and characterize atherosclerotic coronary plaques.
METHODS: Contrast-enhanced CT was performed in 25 human heart specimens with a total of 322 histologically determined plaques. Coronary plaques were classified on CT as (1) noncalcified, mixed, or calcified and (2) by CT attenuation values. Atherosclerotic plaques were histopathologically characterized according to the Stary classification.
RESULTS: CT detected 79% (245/322) of all plaques. Lesions missed by CT were generally early lesions, type I (n = 31), type II (n = 38), or type III (n = 8), according to Stary. CT detected 29% of early (Stary I-III) and 100% of advanced (Stary IV-VIII) plaques. Plaque classification as noncalcified was sensitive (100%) and specific (72%) for early, whereas classification as mixed/calcified was sensitive (92%, 89%) and specific (100%) for advanced plaques. Calcified plaques on CT were detected with high sensitivity (80%) and specificity (95%). Other subtypes were not distinguishable with CT according to the presence or absence of calcification. CT density was significantly higher for advanced (306 ± 470 HU) than for early (42 ± 14 HU; P < 0.01) plaques. The mean CT density value of type VII plaques (512 ± 349 HU) was significantly higher than those of other plaques (34-101 HU; P < 0.001).
CONCLUSIONS: CT reliably depicts advanced coronary plaques and allows for the differentiation between early and advanced plaques.
Copyright © 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20947041     DOI: 10.1016/j.jcct.2010.05.016

Source DB:  PubMed          Journal:  J Cardiovasc Comput Tomogr        ISSN: 1876-861X


  15 in total

1.  Variability and accuracy of coronary CT angiography including use of iterative reconstruction algorithms for plaque burden assessment as compared with intravascular ultrasound-an ex vivo study.

Authors:  Paul Stolzmann; Christopher L Schlett; Pal Maurovich-Horvat; Akiko Maehara; Shixin Ma; Hans Scheffel; Leif-Christopher Engel; Mihály Károlyi; Gary S Mintz; Udo Hoffmann
Journal:  Eur Radiol       Date:  2012-05-24       Impact factor: 5.315

Review 2.  Noninvasive Imaging of Atherosclerotic Plaque Progression: Status of Coronary Computed Tomography Angiography.

Authors:  Veit Sandfort; Joao A C Lima; David A Bluemke
Journal:  Circ Cardiovasc Imaging       Date:  2015-07       Impact factor: 7.792

3.  Comparison of iodinated contrast media for the assessment of atherosclerotic plaque attenuation values by CT coronary angiography: observations in an ex vivo model.

Authors:  L La Grutta; M Galia; G Gentile; G Lo Re; E Grassedonio; F Coppolino; E Maffei; E Maresi; A Lo Casto; F Cademartiri; M Midiri
Journal:  Br J Radiol       Date:  2013-01       Impact factor: 3.039

4.  Atherosclerotic pattern of coronary myocardial bridging assessed with CT coronary angiography.

Authors:  Ludovico La Grutta; Giuseppe Runza; Massimo Galia; Erica Maffei; Giuseppe Lo Re; Emanuele Grassedonio; Carlo Tedeschi; Filippo Cademartiri; Massimo Midiri
Journal:  Int J Cardiovasc Imaging       Date:  2011-02-24       Impact factor: 2.357

5.  Machine learning-based advances in coronary computed tomography angiography.

Authors:  Mina M Benjamin; Mark G Rabbat
Journal:  Quant Imaging Med Surg       Date:  2021-06

6.  Clinical risk factors and atherosclerotic plaque extent to define risk for major events in patients without obstructive coronary artery disease: the long-term coronary computed tomography angiography CONFIRM registry.

Authors:  Alexander R van Rosendael; A Maxim Bax; Jeff M Smit; Inge J van den Hoogen; Xiaoyue Ma; Subhi Al'Aref; Stephan Achenbach; Mouaz H Al-Mallah; Daniele Andreini; Daniel S Berman; Matthew J Budoff; Filippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Kavitha Chinnaiyan; Benjamin J W Chow; Ricardo C Cury; Augustin DeLago; Gudrun Feuchtner; Martin Hadamitzky; Joerg Hausleiter; Philipp A Kaufmann; Yong-Jin Kim; Jonathon A Leipsic; Erica Maffei; Hugo Marques; Pedro de Araújo Gonçalves; Gianluca Pontone; Gilbert L Raff; Ronen Rubinshtein; Todd C Villines; Heidi Gransar; Yao Lu; Jessica M Peña; Fay Y Lin; Leslee J Shaw; James K Min; Jeroen J Bax
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-05-01       Impact factor: 6.875

7.  Beyond Coronary Stenosis: Coronary Computed Tomographic Angiography for the Assessment of Atherosclerotic Plaque Burden.

Authors:  Alan C Kwan; George Cater; Jose Vargas; David A Bluemke
Journal:  Curr Cardiovasc Imaging Rep       Date:  2013-01-22

8.  Dual-energy CT plaque characteristics of post mortem thin-cap fibroatheroma in comparison to infarct-related culprit lesions.

Authors:  Hussam Mahmoud Sheta; Helle Precht; Carol Ann Gloroso Rexen Busk; Laurits Juhl Heinsen; Koen Nieman; Kenneth Egstrup; Jess Lambrechtsen
Journal:  Heart Vessels       Date:  2021-10-04       Impact factor: 2.037

9.  A meta analysis and hierarchical classification of HU-based atherosclerotic plaque characterization criteria.

Authors:  Wisnumurti Kristanto; Peter M A van Ooijen; Marijke C Jansen-van der Weide; Rozemarijn Vliegenthart; Matthijs Oudkerk
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

10.  Different Plaque Composition and Progression in Patients with Stable and Unstable Coronary Syndromes Evaluated by Cardiac CT.

Authors:  Maiken Glud Dalager; Morten Bøttcher; Jesper Thygesen; Gratien Andersen; Hans Erik Bøtker
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.